NCT03919409View on ClinicalTrials.gov

First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 3, 2019

Primary Completion Date

February 11, 2020

Study Completion Date

February 11, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

TS-161

TS-161 capsules

DRUG

TS-161 Placebo

TS-161 matching placebo capsules

Trial Locations (1)

91206

PAREXEL - Early Phase Clinical Unit-Los Angeles, Glendale

All Listed Sponsors
lead

Taisho Pharmaceutical R&D Inc.

INDUSTRY

NCT03919409 - First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants | Biotech Hunter | Biotech Hunter